Combination Chemotherapy of Advanced Hodgkin’s Disease with Adriamycin, DTIC, CCNU, and Bleomycin

Chemotherapy ◽  
1976 ◽  
pp. 513-516
Author(s):  
R. Osieka ◽  
U. Bruntsch ◽  
W. M. Gallmeier ◽  
S. Seeber ◽  
C. G. Schmidt
Keyword(s):  
Combination Chemotherapy ◽  
Hodgkin's Disease ◽  
Hodgkin’S Disease ◽  
Advanced Hodgkin’S Disease

COMBINATION CHEMOTHERAPY (MOPP) IN THE MANAGEMENT OF ADVANCED HODGKIN'S DISEASE: A PROGRESS REPORT ON 55 PATIENTS

1972 ◽  
Vol 1 (2) ◽  
pp. 41-49 ◽  
Author(s):  
I. A. Cooper ◽  
C. Rana ◽  
J. P. Madigan ◽  
R. Motteram ◽  
J. S. Maritz ◽  
...  
Keyword(s):  
Combination Chemotherapy ◽  
Hodgkin's Disease ◽  
Hodgkin’S Disease ◽  
Progress Report ◽  
Advanced Hodgkin’S Disease

Radiotherapy with curative intent: an option in selected patients relapsing after chemotherapy for advanced Hodgkin's disease.

1987 ◽  
Vol 5 (4) ◽  
pp. 550-555 ◽  
Author(s):  
M Roach ◽  
D S Kapp ◽  
S A Rosenberg ◽  
R T Hoppe
Keyword(s):  
Radiation Therapy ◽  
Combination Chemotherapy ◽  
Hodgkin's Disease ◽  
Hodgkin’S Disease ◽  
Complete Response ◽  
Curative Intent ◽  
Major Toxicity ◽  
Disease Free ◽  
Advanced Hodgkin’S Disease

Thirteen patients who had relapsed or failed to obtain a complete remission after combination chemotherapy for the treatment of advanced Hodgkin's disease were treated with subtotal or total lymphoid irradiation with curative intent. Twelve of the 13 patients achieved a complete response (CR). Five of the 12 CRs subsequently relapsed at 3, 9, 9, 12, and 19 months. One patient died of leukemia 11 months following radiotherapy. The actuarial relapse-free survival at 1 year was 60%, and six patients (50%) remain disease-free with a median follow-up of 34 months (range, 10 to 115 months) following the completion of radiotherapy. Patients who failed to obtain a CR to their initial chemotherapy, whose chemotherapy CR was of short duration, or who relapsed initially in extranodal sites, tended to have a worse outcome with radiotherapy. Patients who had long disease-free intervals after initial chemotherapy or relapsed only in nodal sites tended to do relatively well. Radiation therapy was well tolerated with no major toxicity. Potentially curative radiation therapy should be considered an option in the management of selected patients who relapse following combination chemotherapy for advanced Hodgkin's disease.

Radiation therapy salvage of Hodgkin's disease following chemotherapy failure.

1987 ◽  
Vol 5 (1) ◽  
pp. 38-45 ◽  
Author(s):  
K A Fox ◽  
S M Lippman ◽  
J R Cassady ◽  
R S Heusinkveld ◽  
T P Miller
Keyword(s):  
Combination Chemotherapy ◽  
Hodgkin's Disease ◽  
Hodgkin’S Disease ◽  
Statistical Significance ◽  
Disease Free Survival ◽  
Complete Response ◽  
Salvage Radiotherapy ◽  
Wide Field ◽  
Response To Chemotherapy ◽  
Advanced Hodgkin’S Disease

Between 1972 and 1984, 17 patients with advanced Hodgkin's disease failing intensive combination chemotherapy in previously unirradiated nodal and/or pulmonary sites were treated with salvage radiotherapy. Treatment consisted of comprehensive wide field radiotherapy to all known areas of disease. Doses administered to these fields ranged from 1,700 to 5,000 rad, with only three patients (18%) receiving less than 3,000 rad to any field. With a median follow-up of over 4 years, 88% achieved a complete response, with median actuarial disease-free survival (DFS) of 19 months (range, 4 to 61+). Actuarial median survival was 64 months, with a range of 4 to 134+ months. Nine patients (53%) are currently alive with three (18%) in continuous complete remission (CR) for 24, 30, and 61 months. In addition, four patients relapsing after salvage radiotherapy are now in CR following additional therapy. Patients younger than 35 years of age had a significantly increased overall survival when compared with older patients (P less than .005). An initial complete response to chemotherapy lasting 12 or more months appeared to be a favorable prognostic factor, although small patient numbers preclude statistical significance. Comprehensive salvage radiotherapy is of significant benefit in patients with advanced Hodgkin's disease relapsing after combination chemotherapy in nodal and/or pulmonary sites.

scholarly journals A decade of combination chemotherapy of advanced Hodgkin's disease

Cancer ◽  
1972 ◽  
Vol 30 (6) ◽  
pp. 1495-1504 ◽  
Author(s):  
Vincent T. Devita ◽  
George P. Canellos ◽  
John H. Moxley
Keyword(s):  
Combination Chemotherapy ◽  
Hodgkin's Disease ◽  
Hodgkin’S Disease ◽  
Advanced Hodgkin’S Disease

Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy

Cancer ◽  
1978 ◽  
Vol 42 (S2) ◽  
pp. 1001-1007 ◽  
Author(s):  
Robert C. Young ◽  
George P. Canellos ◽  
Bruce A. Chabner ◽  
Susan M. Hubbard ◽  
Vincent T. Devita
Keyword(s):  
Combination Chemotherapy ◽  
Hodgkin's Disease ◽  
Hodgkin’S Disease ◽  
Advanced Hodgkin’S Disease
Sign in / Sign up

Export Citation Format

Share Document